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Curcumin inhibits migration and invasion of non-small 
cell lung cancer cells through up-regulation of miR-206 and 
suppression of PI3K/AKT/mTOR signaling pathway
Curcumin has been proved to inhibit cell proliferation and 
induce cell apoptosis in non-small cell lung cancer (NSCLC). 
However, little is known about antimetastatic effects and 
molecular mechanisms of curcumin in NSCLC. In this 
study, we investigated the involvement of miR-206 in cur-
cumin’s anti-invasion and anti-migration in NSCLC. Cell 
proliferation was determined by MTT assay. Cell migration 
and invasion were analyzed by wound healing assay and 
transwell assay. MiRNA-206 expression was detected by real- 
-time PCR. Western blot was used to detect the protein 
 expression of PI3K/AKT/mTOR signaling pathway. Curcumin 
significantly inhibited migration and invasion in A549 cells, 
accompanied by significantly elevated miR-206 expression. 
Overexpression of miR-206 could inhibit migration and 
inva sion of A549 cells, but it could also significantly decrease 
the phosphorylation levels of mTOR and AKT. The inhibition 
of miR-206 promoted cell migration, invasion and  increased 
the phosphorylation level of mTOR and AKT. Further more, 
miR-206 mimics improved the inhibitory  effects of curcumin 
on cell migration, invasion and the phosphorylation level of 
mTOR and AKT in A549 cells. On the contrary, MiR-206 
 inhibitors reversed the inhibitory effects of curcumin on cell 
migration, invasion and the phosphorylation level of mTOR 
and AKT. In conclusion, curcumin inhibited cell invasion 
and migration in NSCLC by elevating the expression of 
 miR-206 which further suppressed the activation of the 
PI3K/AKT/mTOR pathway.
Keywords: curcumin, NSCLC, microRNAs, migration and 
invasion
Lung cancer is a common malignant tumor worldwide with approximately 80 to 85 % 
of all lung cancers being accounted for non-small cell lung cancer (NSCLC). The incidence 
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ment has been made in the treatment of NSCLC. However, many patients with NSCLC are 
presented with metastasis to existing treatments, such as chemotherapy, radiotherapy and 
surgery (1).
MicroRNAs are small non-codding RNA molecules that regulate a variety of cellular 
processes by binding to the 3’-untranslated region of their target genes (2). In the past 
 decade, accumulated research has indicated that miRNAs play a key regulatory role in the 
occurrence and development of diverse types of cancer, including lung cancer. These 
 studies suggested that miRNAs could be novel diagnostic and therapeutic markers. For 
instance, overexpression of miR-485-5p has been suggested to reduce cell migration and 
invasion via targeting flotillin-2 in small cell lung cancer (3). MiR-1236-3p had been linked 
to DDP resistance in NSCLC (4). In addition, miR-206 plays a tumor-suppressing role in 
lung cancer by suppressing the NSCLC growth, cisplatin resistance, and metastasis via 
targeting Bcl2, c-met, Sox9 and cyclinD1 (5).
Curcumin, a natural polyphenol obtained from the traditional medicine Curcuma 
longa L. (Zingiberaceae), has been investigated widely for its effects for thousands of years 
(6). Several studies have reported that curcumin not only has anti-inflammatory and anti-
oxidant, but also anti-tumor effects (7). The anticancer effect of curcumin was considered 
to inhibit cell proliferation by suppressing multiple cell signaling pathways (8). For example, 
curcumin could induce apoptosis by regulating the miR-21/PTEN/AKT signaling pathway 
in MGC-803 cells (9). Furthermore, curcumin inhibited cell migration and invasion by 
regulating miR-99a and JAK/STAT signaling pathway in retinoblastoma cells (10). Although 
the anti-tumor effects of curcumin have been studied, the exact mechanisms by which 
curcumin affects the NSCLC are still poorly understood.
Since curcumin could change the expression profile of miRNA in various types of 
cancer (11), we hypothesize that curcumin may suppress cell migration and invasion of 
NSCLC through miR-206. Thus, the effects of curcumin and miR-206 on invasion and 
 migration capabilities of A549 cells were investigated. Furthermore, the regulation effect 
of curcumin on the expression of miR-206, which then inhibited migration and invasion in 
A549 cells via attenuating the PI3K/AKT/mTOR signaling pathway was also examined to 
demonstrate that curcumin suppresses invasion and metastasis of NSCLC by increasing 
miR-206 expression.
EXPERIMENTAL
Cell culture and reagents
The A549 cells were obtained from the Shanghai Cell Bank of the Chinese Academy 
of Sciences (Shanghai, China). The cells were cultivated in RPMI-1640 media supplemented 
with 10 % fetal bovine serum (Gibco, Austria) in a humidified incubator at 37 °C in an 
atmosphere of 5 % CO2. The medium contained 100 U mL
–1 penicillin and 100 g mL–1 
strepto mycin. Curcumin was purchased from Sigma (China). The purity of curcumin was 
analyzed by HPLC and is over 99.5 %. Mimic negative control (mimic NC), inhibitor NC, 
miR-206 mimics and miR-206 inhibitors were purchased from GenePharma (China). 
 Primary antibodies AKT, phospho-AKT(S473), mTOR and phospho-mTOR(S2448) were 
purchased from Cell Signaling Technology (USA).
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Cell viability assays
Cell viability was detected by MTT assay. The A549 cells were inoculated in 96-well 
plates (5 × 103 cells/well) and maintained in RPMI-1640 media supplemented with 10 % 
FBS. The A549 cells were cultured overnight, the medium was removed and replaced with 
a new medium. Then, 0, 5, 10, 20 and 40 μmol L–1 curcumin was added to 96-well plates 
and cultured for another 24 hours at 37 °C in an atmosphere of 5 % CO2. Four hours before 
the experiment, A549 cells were incubated in the MTT solution at a density of 0.5 mg mL–1. 
Lastly, the medium with MTT solution was removed and 150 μL of DMSO was added to 
each well. A549 cells were subjected to absorbance measuring by the use of a Microplate 
reader at 490 nm. Each experiment was independently performed 3 times.
MicroRNA transfection
MiR-206 mimics, mimic NC, miR-206 inhibitors and inhibitor NC transfected into 
A549 cells by using Lipofectamine® 2000 reagent (Invitrogen, Carlsbad, CA, USA). Firstly, 
the A549 cells were plated in 6-well plates (1 × 105 cells/well) for 24 hours. Secondly, when 
the density of cells reached 70 %, the A549 cells were transfected with miR-206 mimics, 
mimic NC, miR-206 inhibitors or inhibitor NC for 6 hours according to the instructions of 
Lipofectamine 2000. Finally, the transfected A549 cells were cultivated in new medium 
containing 10 % FBS for another 24 hours.
Migration and invasion assay
The cell migration and invasion were performed by wound healing assay and trans-
well assay. For wound healing assay, the A549 cells were cultured in 6-well plates over-
night. The wound was generated by scratching the cell layer using a 10 μL pipette tip when 
A549 cells reached approximately 90 % confluency. In order to remove non-adherent cells, 
the well plates were washed with PBS and fresh medium without FBS was added for 24 
hours. Then the wound healing effect was detected under microscope at 0 and 24 h. ImageJ 
software measured the area of each wound. Transwell assay was performed in 24-well 
chambers coated with matrigel. A549 cells (3 × 104 cells/well) were plated in 200 μL medium 
without FBS and added into the upper chamber. Subsequently, 600 μL medium with 10 % 
FBS was added to the lower chamber. After the incubation for 24 hours, A549 cells that 
have invaded into the lower surface were fixed with ice methanol and stained with crystal 
violet. Finally, the invaded cells were photographed under a microscope at the magnification 
of 200×.
Real-time PCR analysis
The design of RT-PCR primers was based on miR-206 sequences which were provided 
by the sanger center miRNA registry. Total RNA was extracted from A549 cells which were 
transfected with miR-206 mimics, mimic NC, miR-206 inhibitors or inhibitor NC by using 
TRIzol reagent (Invitrogen). Then, according to the manufacturer’s protocol, 2 μg of total 
RNA has synthesized complementary DNA by AMV reverse transcriptase (Promega, 
Madison, WI, USA). The expression level of miR-206 was detected by mirVana™ qRT-PCR 
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miRNA Detection kit (Invitrogen). Meanwhile, the expression level of U6 was used as in-
ternal control. We used 2−ΔΔCT method to calculate the expression levels of target gene.
Western blotting
Total proteins were extracted from A549 cells using radioimmunoprecipitation assay 
(RIPA) lysis buffer containing PMSF and protease inhibitors. The protein concentration in 
each group was determined by the BCA protein assay. Equivalent protein was separated 
on 10 % SDS-PAGE at 80 V for 2 hours. Then the separated proteins were transferred to 
PVDF membranes at 350 mA for 2 hours. The membranes were treated with 5 % BSA at 
room temperature for one hour to block nonspecific binding, followed closely by the incu-
bation with primary antibodies at 4 °C overnight. The used primary antibodies were rabbit 
anti-phospho-AKT (1:1000 dilution), rabbit anti-phospho-mTOR (1:1000 dilution), rabbit 
anti-AKT antibody (1:1000 dilutions) and rabbit anti-mTOR antibody (1:1000 dilution). The 
membranes were washed with TBST to remove unbounded antibodies. Secondary anti-
bodies (HRP-labeled goat anti-rabbit IgM antibody) were added and the membranes were 
incubated for 1h at room temperature. Protein signals were revealed using ECL, and the 
intensities of scanned bands were performed using the ImageJ software.
Statistical analysis
Statistical analyses of the experimental results were performed using the SPSS 17.0. 
All data were expressed as mean ± SD values. Data were graphed by GraphPad Prism 5.0 
and analyzed by using one-way analysis of variance with the Tukey multiple comparison 
test. All experiments were performed at least three times. p < 0.01 could be considered as 
statistically significant.
RESULTS AND DISCUSSION
Curcumin inhibits cell proliferation in A549 cells
Curcumin, a famous traditional Chinese medicine, has chemo-preventive and thera-
peutic properties against a variety of tumors. Studies have shown that curcumin could sup-
press tumorigenesis, inhibit tumor promotion, and suppress angiogenesis (12). Curcumin 
could not only inhibit cell proliferation of tumor cells, but could also inhibit the proliferation 
of normal cells (13). For example, curcumin significantly inhibited the proliferation of BEAS-2B 
cells at the concentration of 10 μmol L–1 (14). To confirm whether curcumin suppresses cell 
proliferation, A549 cells were treated with curcumin at different concentrations for 24 h, and 
cell viability was detected by MTT assay. The results indicated that curcumin had signifi-
cantly inhibited cell proliferation at concentrations of 10, 20 and 40 μmol L–1, compared with 
the control group, with average rates of cell viabilities of 79.77 ± 2.49 %, 68.95 ± 3.63 % and 
55.53 ± 2.84 %, respectively (Fig. 1). These data showed that curcumin significantly inhibited 
the proliferation of A549 cells in a dose-dependent manner.
Curcumin inhibits migration and invasion in A549 cells
Recently, it was reported that the antitumor effect of curcumin had mainly focused on 
anti-invasion and anti-metastasis (15). However, the effects of curcumin on migration, 
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 invasion and potential molecular mechanisms in lung cancer remain largely unclear. After 
identifying the role of curcumin in cell proliferation, we further investigated its effects on 
migration and invasion of A549 cells according to the literature (6). As shown in Fig. 2, the 
A549 cells were treated with curcumin (0, 10 and 20 μmol L–1) closed 56.42 %, 40.70 % and 
23.35 % of the wounded area for 24 h, respectively. Consistent with the results of wound 
Fig. 1. The effects of curcumin on the viability of A549 cells. A549 cells were treated with curcumin in 
a gradient concentration (0–40 μmol L–1) at 24 h. Data are presented as the mean ± SD, n = 3; **p < 0.01 
vs. control.
Fig. 2. Curcumin inhibited cell migration and invasion in A549 cells. a) A549 cells were scratched with 
a pipette tip and then treated with 10 and 20 μmol L–1 curcumin. Representative images showing the 
inhibitory effect of curcumin on cell migration at 24 h; b) representative images of cells that migrated 
through the polycarbonate membranes in transwell assays stained with crystal violet. Columns, 
mean from three different experiments with three duplicates, **p < 0.01 vs. control.
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healing, the number of invaded cells has significantly decreased compared to untreated 
cells. The invasion capacity of A549 cells decreased 29.01 % and 52.96 %, respectively, com-
pared with the control group at the concentration of 10 and 20 μmol L–1 of curcumin (Fig. 
2). Taken together, the above results indicate that curcumin could suppress cell migration 
and invasion in NSCLC.
miR-206 is upregulated in curcumin-treated A549 cells
MiRNA dysregulation widely occurred in NSCLC, which might contribute to tumor 
occurrence and progression (16). To verify whether curcumin could regulate the expres-
sion of miR-206 in A549 cells, we treated the A549 cells with 10 and 20 μmol L–1 curcumin 
for 24 h. Then the relative expression of miR-206 was detected by real-time RT-PCR. As 
shown in Fig. 3, curcumin has significantly increased the expression level of miR-206 com-
pared to the control group in A549 cells. When the curcumin concentration had been 
 increased to 20 μmol L–1, the expression level of miR-206 increased 2.37-fold relative to the 
untreated cells. It has been reported that miR-206 mimics could suppress migration and 
invasion in NSCLC by targeting c-met (17). Therefore, miR-206 could regard as a potent 
tumor suppressor. In this study, we have found that the treatment of curcumin had elevated 
the expression of miR-206 in A549 cells, suggesting that the regulation of miR-206 expression 
may be correlated with curcumin’s anti-migration and anti-invasion.
miR-206 was involved in the effects of curcumin on cell migration and invasion  
in A549 cells
In order to investigate how miR-206 affected the effects of curcumin on migration and 
invasion of A549 cells, we conducted microRNA transfection. We transfected miR-206 mimics, 
mimic NC, miR-206 inhibitors and inhibitor NC into A549 cells to change the expression of 
miR-206. As shown in Fig. 4a, the mimics and inhibitors of miRNA-206 significantly upregu-
lated and downregulated the miRNA-206 expression in A549 cells, respectively. As shown 
in Fig. 4b and 4c, miR-206 mimics significantly suppressed migration and invasion in A549 
Fig. 3. Relative expression of miR-206 in A549 cells treated with curcumin was detected by real-time 
PCR. A549 cells were treated with different concentrations of curcumin for 24 h and miRNA fold-
inductions by curcumin were evaluated by real-time PCR. **p < 0.01 vs. control.
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Fig. 4. miR-206 inhibits the effect of curcumin on A549 cell migration and invasion. a) A549 cells were 
transfected with miR-206 mimics and miR-206 inhibitors for 24 h. Real-time PCR was used to evaluate 
the expression level of miR-206; b) and c) A549 cells were transfected miR-206 mimics or miR-206 
inhibitors, and then treated with 20 μmol L–1 curcumin, wound-healing assays and transwell inva-
sion assays were used to investigate the migratory and invasive ability of A549 cells, respectively. 
Columns, mean from three different experiments with three duplicates, **p < 0.01 compared with 
negative control and ##p < 0.01 compared with curcumin + negative control.
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cells, while miR-206 inhibitors markedly promoted migration and invasion in A549 cells. 
Moreover, miR-206 mimics transfection markedly increased inhibition of curcumin on mi-
gration and invasion. On the contrary, the miR-206 inhibitor’s transfection had remarkably 
reversed the curcumin’s inhibition of migration and invasion in A549 cells.
Fig. 5. Curcumin increased miR-206 expression to partly prevent the PI3K/AKT/mTOR signaling path-
way. a) and d) Western blot analysis of the expression levels of p-mTOR, mTOR, p-AKT and AKT in 
A549 cells; b), c), e) and f) quantitative data of the levels of p-mTOR and p-AKT. Data are presented 
as the mean ± SD, n = 3; **p < 0.01 compared with negative control and ##p < 0.01 compared with cur-
cumin + negative control.
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Curcumin increases miR-206 expression to partly prevent PI3K/AKT/mTOR signaling 
pathway
The PI3K/AKT/mTOR signaling pathway is commonly activated in NSCLC. More-
over activation of this pathway could promote tumor development through gene muta-
tions, PI3K mutation or amplification, oncogene receptor activation and AKT mutation or 
amplification (18). Accumulating studies have reported that the PI3K/AKT/mTOR signal-
ing pathway is one of the downstream targets of miR-206 (19, 20), therefore, we hypo-
thesized that curcumin inhibited migration and invasion in A549 cells through suppressing 
PI3K/AKT/mTOR signaling pathway. Then, we transfected miR-206 mimics, mimic NC, 
miR-206 inhibitors and inhibitor NC into A549 cells for 24 h. As shown in Fig. 5, miR-206 
mimics have decreased the phosphorylation level of mTOR and AKT, whereas no signifi-
cant changes were observed in the total mTOR and AKT levels. However, miR-206 inhi-
bitors have activated the phosphorylation level of mTOR and AKT. Furthermore, the 
 combined treatment with curcumin and miR-206 mimics could remarkably decrease the 
phosphorylation levels of mTOR and AKT. On the contrary, the combined treatment with 
curcumin and miR-206 inhibitors has partially prevented curcumin’s reduction of the 
phosphorylation levels of AKT and mTOR. These data have demonstrated that curcumin 
might up-regulate miR-206 expression to partly alleviate PI3K/AKT/mTOR signaling 
pathway.
CONCLUSIONS
In this study, we have found the evidence supporting the mechanisms of curcumin’s 
anti-invasion and anti-metastatic effects were correlated with miR-206 in A549 cells. The 
abilities of invasion and migration were significantly inhibited by curcumin in A549 cells 
for 24 h, during which the expression level of miR-206 was determined. The results indi-
cated that the expression level of miR-206 was markedly higher than that in control 
group. Furthermore, the combined treatment with curcumin and miR-206 mimics could 
remarkably decrease the phosphorylation levels of mTOR and AKT. On the contrary, 
combining curcumin treatment with miR-206 inhibitors partially prevented curcumin 
suppressing the phosphorylation level of mTOR and AKT. In summary, this study was 
the first one revealing the involvement of miR-206 in curcumin’s anti-invasion and anti-
migration effects in NSCLC. Based on the results, we concluded that curcumin inhibited 
A549 cell migration and invasion via elevating the expression of miR-206 and suppressing 
activation of the PI3K/AKT/mTOR pathway. The above results of the present study reveal 
that curcumin may be a potential therapeutic drug for anti-invasion and anti-metastasis 
in NSCLC.
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